From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Earnings Preview: Buy Ashmore to take part in the EM recovery

By Graham Neary | Saturday 3 September 2016


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


One of the dirty little secrets in the investment world is that fund management companies – and the very occasional spread betting company – can turn out to be fabulous investments. Investors can often do a lot better by buying shares in these companies than by using their products. In that spirit, let’s have a brief look at Ashmore (ASHM), which is set to release full-year earnings on Tuesday.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 04:57:18